Clinical Trial Update: Disease-modifying Properties of Lithium in the Neurobiology of Alzheimer's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating whether lithium has disease-modifying effects in Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Lithium carbonate (Lithium carbonate)

Snippet

Sponsor: University of Sao Paulo | Conditions: Cognitive Impairment, Alzheimer Disease | Phase 2 | Status: UNKNOWN